These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 30553523)

  • 61. Antibody-drug conjugates (ADCs) delivering pyrrolobenzodiazepine (PBD) dimers for cancer therapy.
    Hartley JA
    Expert Opin Biol Ther; 2021 Jul; 21(7):931-943. PubMed ID: 32543981
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Considerations for the nonclinical safety evaluation of antibody drug conjugates for oncology.
    Roberts SA; Andrews PA; Blanset D; Flagella KM; Gorovits B; Lynch CM; Martin PL; Kramer-Stickland K; Thibault S; Warner G
    Regul Toxicol Pharmacol; 2013 Dec; 67(3):382-91. PubMed ID: 24012707
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Design of next generation antibody drug conjugates].
    Zhu GD; Fu YX
    Yao Xue Xue Bao; 2013 Jul; 48(7):1053-70. PubMed ID: 24133971
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Exploring the effects of linker composition on site-specifically modified antibody-drug conjugates.
    Albers AE; Garofalo AW; Drake PM; Kudirka R; de Hart GW; Barfield RM; Baker J; Banas S; Rabuka D
    Eur J Med Chem; 2014 Dec; 88():3-9. PubMed ID: 25176286
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Multivalent peptidic linker enables identification of preferred sites of conjugation for a potent thialanstatin antibody drug conjugate.
    Puthenveetil S; He H; Loganzo F; Musto S; Teske J; Green M; Tan X; Hosselet C; Lucas J; Tumey LN; Sapra P; Subramanyam C; O'Donnell CJ; Graziani EI
    PLoS One; 2017; 12(5):e0178452. PubMed ID: 28558059
    [TBL] [Abstract][Full Text] [Related]  

  • 66. An FDA oncology analysis of toxicities associated with PBD-containing antibody-drug conjugates.
    Saber H; Simpson N; Ricks TK; Leighton JK
    Regul Toxicol Pharmacol; 2019 Oct; 107():104429. PubMed ID: 31325532
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Development and Properties of Valine-Alanine based Antibody-Drug Conjugates with Monomethyl Auristatin E as the Potent Payload.
    Wang Y; Fan S; Zhong W; Zhou X; Li S
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28841157
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Mathematical modeling of antibody drug conjugates with the target and tubulin dynamics to predict AUC.
    Byun JH; Jung IH
    J Theor Biol; 2018 Apr; 443():113-124. PubMed ID: 29409861
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Peripheral neuropathy with microtubule inhibitor containing antibody drug conjugates: Challenges and perspectives in translatability from nonclinical toxicology studies to the clinic.
    Stagg NJ; Shen BQ; Brunstein F; Li C; Kamath AV; Zhong F; Schutten M; Fine BM
    Regul Toxicol Pharmacol; 2016 Dec; 82():1-13. PubMed ID: 27773754
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Catabolism of antibody drug conjugates and characterization methods.
    Shadid M; Bowlin S; Bolleddula J
    Bioorg Med Chem; 2017 Jun; 25(12):2933-2945. PubMed ID: 28438386
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Introducing Glycolinkers for the Functionalization of Cytotoxic Drugs and Applications in Antibody-Drug Conjugation Chemistry.
    Ekholm FS; Pynnönen H; Vilkman A; Pitkänen V; Helin J; Saarinen J; Satomaa T
    ChemMedChem; 2016 Nov; 11(22):2501-2505. PubMed ID: 27786414
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Sortase Enzyme-Mediated Generation of Site-Specifically Conjugated Antibody Drug Conjugates with High In Vitro and In Vivo Potency.
    Beerli RR; Hell T; Merkel AS; Grawunder U
    PLoS One; 2015; 10(7):e0131177. PubMed ID: 26132162
    [TBL] [Abstract][Full Text] [Related]  

  • 73. An enzymatic deconjugation method for the analysis of small molecule active drugs on antibody-drug conjugates.
    Li Y; Gu C; Gruenhagen J; Yehl P; Chetwyn NP; Medley CD
    MAbs; 2016; 8(4):698-705. PubMed ID: 26891281
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Synthesis and evaluation of pyrrolobenzodiazepine dimer antibody-drug conjugates with dual β-glucuronide and dipeptide triggers.
    Gregson SJ; Barrett AM; Patel NV; Kang GD; Schiavone D; Sult E; Barry CS; Vijayakrishnan B; Adams LR; Masterson LA; D'Hooge F; Snaith M; Harper J; Hartley JA; Howard PW
    Eur J Med Chem; 2019 Oct; 179():591-607. PubMed ID: 31279293
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Antibody-Drug Conjugates as Cancer Therapeutics: Past, Present, and Future.
    Vezina HE; Cotreau M; Han TH; Gupta M
    J Clin Pharmacol; 2017 Oct; 57 Suppl 10():S11-S25. PubMed ID: 28921650
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The development of pyrrolobenzodiazepines as antitumour agents.
    Hartley JA
    Expert Opin Investig Drugs; 2011 Jun; 20(6):733-44. PubMed ID: 21457108
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Physical and Chemical Stability of Antibody Drug Conjugates: Current Status.
    Ross PL; Wolfe JL
    J Pharm Sci; 2016 Feb; 105(2):391-397. PubMed ID: 26869406
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Exploring alternative antibody scaffolds: Antibody fragments and antibody mimics for targeted drug delivery.
    Richards DA
    Drug Discov Today Technol; 2018 Dec; 30():35-46. PubMed ID: 30553519
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effect of microwave irradiation on covalent ligand-DNA interactions.
    Rahman KM; Thurston DE
    Chem Commun (Camb); 2009 May; (20):2875-7. PubMed ID: 19436895
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Antibody-drug conjugate payloads.
    Anderl J; Faulstich H; Hechler T; Kulke M
    Methods Mol Biol; 2013; 1045():51-70. PubMed ID: 23913141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.